You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

azacitidine

Showing 1 - 25 of 306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
Nov 17, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Azacitidine
  • +2 more
  • (no location specified)
Mar 15, 2023

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Azacitidine
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
Aug 22, 2022

Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

Not yet recruiting
  • Leukemia, Juvenile Myelomonocytic
  • +4 more
  • (no location specified)
May 4, 2023

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • NanJing, China
    Department of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • AMG 176
  • Azacitidine
  • (no location specified)
Jul 29, 2022

DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Azacitidine
  • +2 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Azacitidine
  • Placebo
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Azacitidine
  • +2 more
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

MDS Trial in Saint Louis (vosaroxin, Azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 23, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Azacitidine
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 12, 2022

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

Not yet recruiting
  • AML, Adult
  • Hangzhou, China
  • +3 more
Feb 12, 2023

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

Recruiting
  • Secondary Myelodysplastic Syndrome
  • Therapy-Related Myelodysplastic Syndrome
  • Azacitidine
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022

Myeloid Malignancy Trial in Detroit (azacitidine)

Recruiting
  • Myeloid Malignancy
  • azacitidine
  • Detroit, Michigan
    Henry ford hospital
Dec 23, 2021